世界中の市場調査レポートを販売!当社に無いレポートもお探しします。

レポートナンバー 0000032513

インスリン市場規模、シェア、動向分析レポート、予測2022-2030

Grand View Research Inc.

Insulin Market Size, Share & Trends Analysis By Product Type (Rapid-Acting Insulin, Long-Acting Insulin, Combination Insulin, Biosimilar), By Application, By Type (Type 1, Type 2), By Distribution Channel, By Region, And Segment Forecasts, 2022 - 2030

発刊日 2022/07

言語英語

体裁PDF/150ページ

ライセンス/価格150ページ

0000032513

Individual
Team
Enterprise

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。

無料サンプル

  • サンプルはお問い合わせください。

レポート概要

ンスリン市場の規模、シェア、動向分析製品タイプ(速効型インスリン、長時間作用型インスリン、インスリン配合剤、バイオシミラー)、用途別、タイプ別(1型、2型)、流通経路別、地域別、およびセグメント予測、2022〜2030

レポートの概要
世界のインスリン市場の規模は2021年に203億5000万ドルと推定され、2022年から2030年までに1.5%のCAGRで拡大すると予想されます。インスリン市場は、糖尿病の発生率の増加や製剤の進歩などによって成長を遂げています。ただし、2型糖尿病を治療するためのGLP-1 RAなどの薬剤の処方が増えると、市場の成長が鈍化する可能性があります。これは、ノボノルディスクA / S、サノフィ、イーライリリーアンドカンパニーなどの企業が支配する寡占領域です。糖尿病は、世界で最も急速に増加している慢性疾患の1つです。その有病率は過去数十年にわたって着実に増加しています。

レポート詳細

目次

Table of Contents

Chapter 1 Methodology and Scope
1.1 Market segmentation
1.1.1 Estimates and forecast timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased database
1.3.2 GVR’S internal database
1.3.3 Secondary sources
1.3.4 Primary research
1.3.5 Details of primary research
1.3.6 List of primary sources
1.4 Information or data analysis
1.4.1 Data analysis models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity flow analysis
1.6.1.1 Approach 1: Commodity Flow Approach
1.6.1.2 Approach 2: Country-wise market estimation using the bottom-up approach
1.7 Global Market: CAGR Calculation
1.8 Research Assumptions
1.9 List of Secondary Sources
1.10 List of Abbreviations
1.11 Objectives
1.11.1 Objective 1
1.11.2 Objective 2
1.11.3 Objective 3
1.11.4 Objective 4

Chapter 2 Executive Summary
2.1 Market Summary

Chapter 3 Market Variables, Trends & Scope
3.1 Market Lineage Outlook
3.1.1 Parent market outlook
3.2 Regulatory framework
3.3 Penetration and Growth Prospect Mapping
3.4 Pipeline Analysis
3.5 Market Dynamics
3.5.1 Market driver analysis
3.5.1.1 Increase in prevalence of diabetes
3.5.1.2 Increase in geriatric and obese population
3.5.1.3 Formulation advancements in insulin delivery systems
3.5.2 Market restraint analysis
3.5.2.1 High cost of insulin
3.5.2.2 Poor reimbursement policies
3.5.2.3 Launch of insulin biosimilars and increasing penetration of glp-1 agonists
3.6 Porter's Five Forces Analysis
3.7 PESTEL Analysis
3.8 COVID-19 Impact

Chapter 4 Global Insulin Market - Segment Analysis, By Product Type, 2018 - 2030 (USD Million)
4.1 Global Insulin Market: Product Type Movement Analysis
4.2 Rapid-Acting Insulin
4.2.1 Rapid-acting insulin market estimates and forecast, 2018 - 2030 (USD Million)
4.3 Long-acting Insulin
4.3.1 Long-acting insulin market estimates and forecast, 2018 - 2030 (USD Million)
4.4 Combination Insulin
4.4.1 Combination insulin market estimates and forecast, 2018 - 2030 (USD Million)
4.5 Biosimilar
4.5.1 Biosimilar market estimates and forecast, 2018 - 2030 (USD Million)
4.6 Others
4.6.1 Other market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 5 Global Insulin Market - Segment Analysis, By Type, 2018 - 2030 (USD Million)
5.1 Global Insulin Market: Type Movement Analysis
5.2 Human Insulin
5.2.1 Human Insulin Market Estimates and Forecast, 2018 - 2030 (USD Million)
5.3 Insulin Analog
5.3.1 Insulin Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6 Global Insulin Market - Segment Analysis, Application, 2018 - 2030 (USD Million)
6.1 Global Insulin Market: Application Movement Analysis
6.2 Type 1 Diabetes Mellitus
6.2.1 Type 1 diabetes mellitus market estimates and forecast, 2018 - 2030 (USD Million)
6.3 Type 2 Diabetes Mellitus
6.3.1 Type 2 diabetes mellitus market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 7 Global Insulin Market - Segment Analysis, By Distribution Channel, 2018 - 2030 (USD Million)
7.1 Global Insulin Market: Distribution Channel Movement Analysis
7.2 Hospital Pharmacy
7.2.1 Hospital pharmacy market estimates and forecast, 2018 - 2030 (USD Million)
7.3 Retail Pharmacy
7.3.1 Retail pharmacy market estimates and forecast, 2018 - 2030 (USD Million)
7.4 Others
7.4.1 Other market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 8 Insulin Market: Segment Analysis, by region, 2018 - 2030 (USD Million)
8.1 Insulin Market: Regional Movement Analysis
8.1.1 North America
8.1.1.1 North America market estimates and forecast, 2018 - 2030 (USD Million)
8.1.1.2 U.S.
8.1.1.2.1 U.S. market estimates and forecast, 2018 - 2030 (USD Million)
8.1.1.3 Canada
8.1.1.3.1 Canada market estimates and forecast, 2018 - 2030 (USD Million)
8.1.2 Europe
8.1.2.1 Europe market estimates and forecast, 2018 - 2030 (USD Million)
8.1.2.2 UK
8.1.2.2.1 UK market estimates and forecast, 2018 - 2030 (USD Million)
8.1.2.3 Germany
8.1.2.3.1 Germany market estimates and forecast, 2018 - 2030 (USD Million)
8.1.2.4 France
8.1.2.4.1 France market estimates and forecast, 2018 - 2030 (USD Million)
8.1.2.5 Spain
8.1.2.5.1 Spain market estimates and forecast, 2018 - 2030 (USD Million)
8.1.2.6 Italy
8.1.2.6.1 Italy market estimates and forecast, 2018 - 2030 (USD Million)
8.1.3 Asia Pacific
8.1.3.1 Asia Pacific market estimates and forecast, 2018 - 2030 (USD Million)
8.1.3.2 Japan
8.1.3.2.1 Japan market estimates and forecast, 2018 - 2030 (USD Million)
8.1.3.3 China
8.1.3.3.1 China market estimates and forecast, 2018 - 2030 (USD Million)
8.1.3.4 India
8.1.3.4.1 India market estimates and forecast, 2018 - 2030 (USD Million)
8.1.3.5 Australia
8.1.3.5.1 Australia market estimates and forecast, 2018 - 2030 (USD Million)
8.1.3.5 South Korea
8.1.3.5.1 South Korea market estimates and forecast, 2018 - 2030 (USD Million)
8.1.4 Latin America
8.1.4.1 Latin America market estimates and forecast, 2018 - 2030 (USD Million)
8.1.4.2 Brazil
8.1.4.2.1 Brazil market estimates and forecast, 2018 - 2030 (USD Million)
8.1.4.3 Mexico
8.1.4.3.1 Mexico market estimates and forecast, 2018 - 2030 (USD Million)
8.1.4.4 Argentina
8.1.4.4.1 Argentina market estimates and forecast, 2018 - 2030 (USD Million)
8.1.5 Middle East & Africa
8.1.5.1 Middle East & Africa market estimates and forecast, 2018 - 2030 (USD Million)
8.1.5.2 South Africa
8.1.5.2.1 South Africa market estimates and forecast, 2018 - 2030 (USD Million)
8.1.5.3 Saudi Arabia
8.1.5.3.1 Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
8.1.5.5 United Arab Emirates
8.1.5.5.1 United Arab Emirates market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 9 Global Insulin Market: Competitive Analysis
9.1 Recent Developments and Impact Analysis, by Key Market Participants
9.1.1 Synergy analysis: major deals and strategic alliances
9.1.1.1 New Product Launches
9.1.1.2 Mergers and Acquisitions
9.1.1.3 Partnerships & Agreements
9.2 Company Categorization
9.2.1 Innovators
9.2.2 Market Leaders
9.2.3 Emerging Players
9.2.4 Heat Map Analysis
9.3 Company Market Position Analysis
9.4 Vendor Landscape
9.4.1 List of Key Distributors and Channel Partners
9.4.2 List of Potential End-Users
9.4.3 Key Company Market Share Analysis, 2021
9.5 Company Market Share/Ranking, 2021
9.5.1 Company Market Share/Ranking, Rapid-Acting Insulin, 2021
9.5.2 Company Market Share/Ranking, Long-Acting Insulin, 2021
9.5.3 Company Market Share/Ranking, Biosimilars, 2021
9.5.4 Company Market Share/Ranking, Others, 2021
9.5.5 Competitive Dashboard Analysis
9.6 Private Companies
9.6.1 List of Key Emerging Companies
9.6.2 Regional Network Map
9.7 Company Profiles
9.7.1 Eli Lilly and Company
9.7.1.1 Company overview
9.7.1.2 Financial performance
9.7.1.3 Product benchmarking
9.7.1.4 Strategic initiatives
9.7.2 Sanofi
9.7.2.1 Company overview
9.7.2.2 Financial performance
9.7.2.3 Product benchmarking
9.7.2.4 Strategic initiatives
9.7.3 Novo Nordisk A/S
9.7.3.1 Company overview
9.7.3.2 Financial performance
9.7.3.3 Product benchmarking
9.7.3.4 Strategic initiatives
9.7.4 Biocon
9.7.4.1 Company overview
9.7.4.2 Financial performance
9.7.4.3 Product benchmarking
9.7.4.4 Strategic initiatives
9.7.5 Boehringer Ingelheim International GmbH
9.7.5.1 Company overview
9.7.5.2 Financial performance
9.7.5.3 Product benchmarking
9.7.5.4 Strategic initiatives
9.7.6 Tonghua Dongbao Pharmaceutical Co. Ltd.
9.7.6.1 Company overview
9.7.6.2 Product benchmarking
9.7.6.3 Strategic initiatives
9.7.7 Wockhardt
9.7.7.1 Company overview
9.7.7.2 Financial performance
9.7.7.3 Product benchmarking
9.7.8 Julphar
9.7.8.1 Company overview
9.7.8.2 Financial performance
9.7.8.3 Product benchmarking
9.7.8.4 Strategic initiatives
9.7.9 The United Laboratories International Holdings Limited
9.7.9.1 Company overview
9.7.9.2 Financial performance
9.7.9.3 Product benchmarking

List of Tables
Table 1 List of secondary sources
Table 2 List of Abbreviations
Table 3 North America insulin market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 4 North America insulin market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 5 North America insulin market estimates and forecasts, by type, 2018 - 2030 (USD Million)
Table 6 North America insulin market estimates and forecasts, by distribution channel, 2018 - 2030 (USD Million)
Table 7 U.S. insulin market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 8 U.S. insulin market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 9 U.S. insulin market estimates and forecasts, by type, 2018 - 2030 (USD Million)
Table 10 U.S. insulin market estimates and forecasts, by distribution channel, 2018 - 2030 (USD Million)
Table 11 Canada insulin market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 12 Canada insulin market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 13 Canada insulin market estimates and forecasts, by type, 2018 - 2030 (USD Million)
Table 14 Canada insulin market estimates and forecasts, by distribution channel, 2018 - 2030 (USD Million)
Table 15 Europe insulin market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 16 Europe insulin market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 17 Europe insulin market estimates and forecasts, by type, 2018 - 2030 (USD Million)
Table 18 Europe insulin market estimates and forecasts, by distribution channel, 2018 - 2030 (USD Million)
Table 19 UK insulin market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 20 UK insulin market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 21 UK insulin market estimates and forecasts, by type, 2018 - 2030 (USD Million)
Table 22 UK insulin market estimates and forecasts, by distribution channel, 2018 - 2030 (USD Million)
Table 23 Germany insulin market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 24 Germany insulin market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 25 Germany insulin market estimates and forecasts, by type, 2018 - 2030 (USD Million)
Table 26 Germany insulin market estimates and forecasts, by distribution channel, 2018 - 2030 (USD Million)
Table 27 France insulin market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 28 France insulin market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 29 France insulin market estimates and forecasts, by type, 2018 - 2030 (USD Million)
Table 30 France insulin market estimates and forecasts, by distribution channel, 2018 - 2030 (USD Million)
Table 31 Italy insulin market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 32 Italy insulin market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 33 Italy insulin market estimates and forecasts, by type, 2018 - 2030 (USD Million)
Table 34 Italy insulin market estimates and forecasts, by distribution channel, 2018 - 2030 (USD Million)
Table 35 Spain insulin market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 36 Spain insulin market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 37 Spain insulin market estimates and forecasts, by type, 2018 - 2030 (USD Million)
Table 38 Spain insulin market estimates and forecasts, by distribution channel, 2018 - 2030 (USD Million)
Table 39 Asia Pacific insulin market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 40 Asia Pacific insulin market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 41 Asia Pacific insulin market estimates and forecasts, by type, 2018 - 2030 (USD Million)
Table 42 Asia Pacific insulin market estimates and forecasts, by distribution channel, 2018 - 2030 (USD Million)
Table 43 Japan insulin market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 44 Japan insulin market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 45 Japan insulin market estimates and forecasts, by type, 2018 - 2030 (USD Million)
Table 46 Japan insulin market estimates and forecasts, by distribution channel, 2018 - 2030 (USD Million)
Table 47 China insulin market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 48 China insulin market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 49 China insulin market estimates and forecasts, by type, 2018 - 2030 (USD Million)
Table 50 China insulin market estimates and forecasts, by distribution channel, 2018 - 2030 (USD Million)
Table 51 India insulin market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 52 India insulin market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 53 India insulin market estimates and forecasts, by type, 2018 - 2030 (USD Million)
Table 54 India insulin market estimates and forecasts, by distribution channel, 2018 - 2030 (USD Million)
Table 55 Australia insulin market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 56 Australia insulin market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 57 Australia insulin market estimates and forecasts, by type, 2018 - 2030 (USD Million)
Table 58 Australia insulin market estimates and forecasts, by distribution channel, 2018 - 2030 (USD Million)
Table 59 South Korea insulin market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 60 South Korea insulin market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 61 South Korea insulin market estimates and forecasts, by type, 2018 - 2030 (USD Million)
Table 62 South Korea insulin market estimates and forecasts, by distribution channel, 2018 - 2030 (USD Million)
Table 63 Latin America insulin market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 64 Latin America insulin market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 65 Latin America insulin market estimates and forecasts, by type, 2018 - 2030 (USD Million)
Table 66 Latin America insulin market estimates and forecasts, by distribution channel, 2018 - 2030 (USD Million)
Table 67 Brazil insulin market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 68 Brazil insulin market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 69 Brazil insulin market estimates and forecasts, by type, 2018 - 2030 (USD Million)
Table 70 Brazil insulin market estimates and forecasts, by distribution channel, 2018 - 2030 (USD Million)
Table 71 Mexico insulin market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 72 Mexico insulin market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 73 Mexico insulin market estimates and forecasts, by type, 2018 - 2030 (USD Million)
Table 74 Mexico insulin market estimates and forecasts, by distribution channel, 2018 - 2030 (USD Million)
Table 75 Argentina insulin market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 76 Argentina insulin market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 77 Argentina insulin market estimates and forecasts, by type, 2018 - 2030 (USD Million)
Table 78 Argentina insulin market estimates and forecasts, by distribution channel, 2018 - 2030 (USD Million)
Table 79 MEA insulin market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 80 MEA insulin market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 81 MEA insulin market estimates and forecasts, by type, 2018 - 2030 (USD Million)
Table 82 MEA insulin market estimates and forecasts, by distribution channel, 2018 - 2030 (USD Million)
Table 8 South Africa insulin market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 82 South Africa insulin market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 83 South Africa insulin market estimates and forecasts, by type, 2018 - 2030 (USD Million)
Table 84 South Africa insulin market estimates and forecasts, by distribution channel, 2018 - 2030 (USD Million)
Table 85 Saudi Arabia insulin market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 86 Saudi Arabia insulin market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 87 Saudi Arabia insulin market estimates and forecasts, by type, 2018 - 2030 (USD Million)
Table 88 Saudi Arabia insulin market estimates and forecasts, by distribution channel, 2018 - 2030 (USD Million)
Table 90 UAE insulin market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 91 UAE insulin market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 92 UAE insulin market estimates and forecasts, by type, 2018 - 2030 (USD Million)
Table 93 UAE insulin market estimates and forecasts, by distribution channel, 2018 - 2030 (USD Million)
Table 94 List of key distributors

List of Figures
Fig. 1 Global Insulin market segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 Commodity flow analysis
Fig. 10 Global insulin market snapshot, 2021
Fig. 11 Penetration and growth prospect mapping
Fig. 12 Global insulin market driver impact
Fig. 13 Global diabetes prevalence data and forecast (Numbers in millions)
Fig. 14 Global Insulin Market Restraint Impact
Fig. 15 Sources of healthcare financing according to country income, 2020 (%)
Fig. 16 Porter's five forces analysis
Fig. 17 Global insulin market: Product type outlook and key takeaways
Fig. 18 Global insulin market: Product type movement analysis
Fig. 19 Rapid-acting insulin market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 20 Long-acting insulin market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 21 Combination Insulin market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 22 Biosimilar market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 23 Other market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 24 Global insulin market: type outlook and key takeaways
Fig. 25 Global insulin market: Type movement analysis
Fig. 26 Human insulin market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 27 Insulin analog market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 28 Global insulin market: Application type outlook and key takeaways
Fig. 29 Global insulin market: Application type movement analysis
Fig. 30 Type 1 diabetes mellitus market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 31 Type 2 diabetes mellitus market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 32 Global insulin market: Distribution channel outlook and key takeaways
Fig. 33 Global insulin market: Distribution channel movement analysis
Fig. 34 Hospital pharmacy market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 35 Retail pharmacy market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 36 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 38 Regional marketplace: Key takeaways
Fig. 39 Regional outlook, 2018 & 2030
Fig. 40 North America insulin market, 2018 - 2030 (USD Million)
Fig. 41 U.S. insulin market, 2018 - 2030 (USD Million)
Fig. 42 Canada insulin market, 2018 - 2030 (USD Million)
Fig. 43 Europe insulin market, 2018 - 2030 (USD Million)
Fig. 44 UK. insulin market, 2018 - 2030 (USD Million)
Fig. 45 Germany insulin market, 2018 - 2030 (USD Million)
Fig. 46 Italy insulin market, 2018 - 2030 (USD Million)
Fig. 47 Spain insulin market, 2018 - 2030 (USD Million)
Fig. 48 France insulin market, 2018 - 2030 (USD Million)
Fig. 49 Asia Pacific insulin market, 2018 - 2030 (USD Million)
Fig. 50 Japan insulin market, 2018 - 2030 (USD Million)
Fig. 52 India insulin market, 2018 - 2030 (USD Million)
Fig. 53 Australia insulin market, 2018 - 2030 (USD Million)
Fig. 54 South Korea insulin market, 2018 - 2030 (USD Million)
Fig. 55 Latin America insulin market, 2018 - 2030 (USD Million)
Fig. 56 Brazil insulin market, 2018 - 2030 (USD Million)
Fig. 57 Mexico insulin market, 2018 - 2030 (USD Million)
Fig. 58 Argentina insulin market, 2018 - 2030 (USD Million)
Fig. 59 MEA insulin market, 2018 - 2030 (USD Million)
Fig. 60 South Africa insulin market, 2018 - 2030 (USD Million)
Fig. 61 Saudi Arabia insulin market, 2018 - 2030 (USD Million)
Fig. 62 UAE insulin market, 2018 - 2030 (USD Million)
Fig. 63 Heat map analysis
Fig. 64 Company market position analysis, 2021
Fig. 65 Company market position analysis, 2021
Fig. 66 Company market share analysis (2021)
Fig. 67 Market differentiators

この商品のレポートナンバー

0000032513

TOP